Yes PK - big pharma holds back too often and how many compounds just disappear if those small companies go under.
At least the company involved had 99.9% success with its antiviral - so maybe only one mouse bit the dust.
I can't see that the road will be smooth for MXC - they have too little in way of products (and revenue) and they are heavily in debt. They are racking up some successes - but they have done that before and then there were disappointing ends to that story.
Still not convinced about them as a company but I do wish them - and shareholders well into the future.
I do have a couple of Biotech shares and I think I would prefer those to MXC.
MXC Price at posting:
4.5¢ Sentiment: None Disclosure: Not Held
